Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epilepsy Treatment
100%
Glycine
100%
Augmentation Therapy
100%
Temporal Lobe Epilepsy
60%
Glycine Transporter
46%
Homeostasis
20%
Seizure
20%
Mouse Model
13%
Seizure Control
13%
Pharmacological Principles
13%
GlyT1 Inhibitor
13%
Anticonvulsant
13%
Schizophrenia
13%
Procognitive
13%
Innovative Use
6%
Development Effort
6%
Dual Role
6%
Acute Symptomatic Seizures
6%
Chronic Epilepsy
6%
Epilepsy Therapy
6%
Cognitive Activity
6%
Mechanistic Studies
6%
Neuronal Excitability
6%
Expected Outcomes
6%
Cognitive Function
6%
Behavioral Tests
6%
Cognitive Impairment
6%
Expected Impact
6%
Pathophysiological Mechanisms
6%
Alternative Drugs
6%
Therapeutic Study
6%
Anticonvulsive
6%
Antiepileptic Drugs
6%
Expected Benefits
6%
Epilepsy
6%
Rodent Models
6%
Goal-oriented
6%
Gaps in Knowledge
6%
Glycine Receptor
6%
Cognitive Effects
6%
Clinical Development
6%
Pathophysiology
6%
Rodents
6%
Clinical Translation
6%
Seizure Suppression
6%
N-methyl-D-aspartate Receptor (NMDAR)
6%
Clinical Trial Phase II
6%
Genetic Tools
6%
Existing Drugs
6%
Therapeutic Drug Development
6%
Hippocampus
6%
Seizure Threshold
6%
Specific Intent
6%
Experimental Tools
6%
Medicine and Dentistry
Temporal Lobe Epilepsy
100%
Treatment of Epilepsy
100%
Epileptic Seizure
88%
Homeostasis
33%
Anticonvulsant
33%
Pathophysiology
11%
Cognitive Defect
11%
Clinical Trial
11%
Cognitive Effect
11%
Excitability
11%
Epilepsy Therapy
11%
Hippocampus
11%
N Methyl-D-Aspartate Receptor
11%
Side Effect
11%
Glycine Receptor
11%
Seizure Threshold
11%
Cognition
11%
Neuroscience
Temporal Lobe Epilepsy
100%
Treatment of Epilepsy
100%
Anticonvulsant
33%
Cognitive Disorders
11%
Behavioral Test
11%
Hippocampus
11%
Glycine Receptor
11%
Cognitive Effect
11%
Epilepsy Therapy
11%
Cognitive Function
11%
Neuronal Excitability
11%
Aspartic Acid
11%
Receptor
11%